Suspension of USAID funding by Trump administration likely violated Constitution, judge says
For the second time, a federal judge has ordered the Trump administration to pay out money Congress appropriated to foreign ...
McKnight's Long-Term Care News20h
How to do it … Supporting temporary staff on med passes
Workforce shortages continue to create challenges, including when it comes to medication management in nursing homes.
Compound versions of weight loss drugs will no longer be available, FDA rules
The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...
Good Morning America12h
Compound versions of some weight loss drugs to be restricted
The agency has ordered compounding pharmacies to stop making compound versions of GLP-1 drugs now that the drugs are no longer in short supply. Eli Lilly, the maker of Zepbound and Mounjaro, and Novo ...
Standard-Journal4h
LGM Pharma Invests $6M in U.S. Drug Manufacturing Capabilities for Liquids, Suspensions, Semi-Solids, and Suppositories
This investment comes as LGM Pharma experiences sustained growth in prescription drug projects, including 505 (b) (2) and Abbreviated New Drug Application (ANDA) programs. The Rosenberg facility ...